The use of most antipsychotics during pregnancy does not appear to increase the risk of neurodevelopmental disorders such as autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD) in the offspring, according to a comprehensive study published in JAMA Internal Medicine. The one exception was in children whose mothers took aripiprazole during pregnancy, which was linked with a 36% increased risk of a diagnosis of a neurodevelopmental disorder.